Home Newsfeeds Odeon Capital Downgrades KeyCorp to Hold

Odeon Capital Downgrades KeyCorp to Hold

Odeon Capital analyst Dick Bove downgrades KeyCorp (NYSE:KEY) from Buy to Hold.

byBenzinga Newsdesk

March 13, 2023

1 minute read

Odeon Capital analyst Dick Bove downgrades KeyCorp (NYSE:KEY) from Buy to Hold.

Needham Maintains Buy on Applied Materials, Lowers Price Target to $90

By Benzinga Newsdesk

October 13, 7:41 AM

Needham analyst Quinn Bolton maintains Applied Materials (NASDAQ:AMAT) with a Buy and lowers the price target from $125 to $90.

AMAT

American Airlines’ Revenue Tracking Well As Demand Picks Up, Says Analyst

By Shivani Kumaresan

November 29, 1:05 PM

Raymond James analyst Savanthi Syth has reiterated a Market Perform rating on the shares of American Airlines Group Inc (NASDAQ: AAL).

AAL

ImmunoGen’s Newly Approved Ovarian Cancer Drug Listed As Preferred Regime

By Vandana Singh

December 28, 1:56 PM

The National Comprehensive Cancer Network (NCCN) released new guidelines for ovarian cancer treatment, which include ImmunoGen Inc's (NASDAQ: IMGN) Elahere (mirvetuximab soravtansine-gynx) as a preferred regimen.

IMGN

Flutter Earnings Continue To Show FanDuel’s US Dominance: What Investors Should Know About This OTC Stock

By AJ Fabino

August 13, 3:15 PM

One of the leading online sports betting companies was the feature of the earnings report from European gaming company Flutter Entmt ADR (OTC: PDYPY).

PDYPY

Odeon Capital Downgrades KeyCorp to Hold

Related Posts

Needham Maintains Buy on Applied Materials, Lowers Price Target to $90

American Airlines’ Revenue Tracking Well As Demand Picks Up, Says Analyst

ImmunoGen’s Newly Approved Ovarian Cancer Drug Listed As Preferred Regime

Flutter Earnings Continue To Show FanDuel’s US Dominance: What Investors Should Know About This OTC Stock